|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||18.17 - 18.17|
|52-week range||16.66 - 25.36|
|Beta (5Y monthly)||0.27|
|PE ratio (TTM)||10.50|
|Forward dividend & yield||0.59 (3.26%)|
|Ex-dividend date||28 Mar 2024|
|1y target est||N/A|
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.
Ono Pharmaceutical Co. (OPHLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OPHLF, TOELY and TLYS have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2023.